Discover 1,253 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,253
FeaturedActive & Responsive
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
for
Psoriatic Arthritis, Axial Spondyloarthritis
Location: Murfreesboro TN, Jackson TN, Vandalia OH, Rock Hill SC,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 18+
Code: NCT07290036
Phase 1, Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: Smyrna TN, Bowling Green KY, Douglasville GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Phase 4, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Study of EVO756 in Adults With Migraine
for
Migraine
Location: Franklin TN, Atlanta GA, Decatur GA, Asheville NC,
Sponsor: Evommune, Inc.
Sex: All
Age: 18 - 64
Code: NCT07616128
Phase 2, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Nashville TN, Louisville KY, New Albany IN, Atlanta GA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase 3, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
for
Moderate to Severe Chronic Obstructive Pulmonary Disease
Location: Franklin TN, Hendersonville TN, Birmingham AL,
Sponsor: Pfizer
Sex: All
Age: 35 - 70+
Code: NCT07363694
Phase 2, Phase 3, Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for
Heart Failure With Preserved Ejection Fraction,
Location: Tullahoma TN, Huntsville AL, Oak Ridge TN, Powell TN,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037459
Phase 3, Recruiting
Active & Responsive
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
for
Idiopathic Pulmonary Fibrosis (IPF)
Location: Franklin TN, Knoxville TN, Rock Hill SC, Greensboro NC,
Sponsor: PureTech
Sex: All
Age: 40+
Code: NCT07284602
Phase 3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer